References
1. G. Fontana et al., Drug Deliv.
12 (6), 385–392 (2005).
2. V.C. Jordan, Br. J. Pharmacol.
110 (2), 507–517 (1993).
3. E. Memisoglu-Bilensoy et al., J. Control. Release
104 (3), 489–496 (2005).
4. J.S. Chawla and M.M. Amiji, Int. J. Pharm.
249 (1–2), 127–138 (2002).
5. K. Jores et al., Pharm. Res.
22 (11), 1887–1897 (2005).
6. H. Yuan et al., Colloids Surf. B. Biointerfaces
61 (2), 132–137 (2007).
7. K. Westesen, H. Bunjes, and M.H.J. Koch, J. Control. Release
48 (2–3,), 223–236 (1997).
8. A.Z. Mühlen, C.Schwarz, and W.Mehnert, Eur. J. Pharm. Biopharm.
45 (2), 149–155 (1998).
9. M.A. Schubert and C.C. Müller-Goymann, Eur. J. Pharm. Biopharm.
61 (1–2), 77–86 (2005).
10. R. Lander et al., Biotechnology Progress
16 (1), 80–85 (2000).
11. A.A. Attama and C.C. Müller-Goymann, Int. J. Pharm.
334 (1–2), 179–189 (2007).
12. I. Mountasser, H. Fessi, and A.W. Coleman, Eur. J. Pharm. Biopharm.
54 (3), 281–284 (2002).
13. I. Brigger et al., Int. J. Pharm.
214 (1–2), 37–42 (2001).
14. F. Ikom, G.K. Hanna, and G.W. Schmid-Schmid, Lymphology
32 (3), 90–102 (1999).
15. D.Z. Hou et al., Biomater.
24 (10), 1781–1785 (2003).
16. H.L. Reddy et al., Pharm. Dev. Tech.
11 (2), 167–177 (2006).
17. H.L. Wong et al., J. Pharm. Sci.
93 (8), 1993–2008 (2004).
18. H. Yuan et al., Int. J. Pharm.
348 (1–2), 137–145 (2008).
19. A. Maschke et al., Eur. J. Pharm. Biopharm.
65 (2), 175–187 (2007).
20. S.A. Wissing, O. Kayser, and R.H. Müller, Adv. Drug Deliv. Rev.
56 (9), 1257–1272 (2004).
21. L. Serpe et al., Anticancer Drug
15 (5), 525–536 (2004).
Citation: When referring to this article, please cite it as "R.Abbasalipourkabir, .Salehzadeh, R.Abdullah, "Delivering Tamoxifen
Within Solid Lipid Nanoparticles,"Pharmaceutical Technology 35 (4) 74-80 (2011)."
|
